Solvo Biotechnology – “The Transporter Company” is a privately held biopharmaceutical company established in 1999 by a group of pre-eminent scientists working in the areas of ABC transporter proteins and multi-drug resistance at leading Hungarian universities. The company holds patents relating to drug targets and modulators, gene therapy applications and functional aspects of pharmacogenetics. In the past few years there has been an explosion in our understanding of the role Membrane Transporters play in the ADMETox profiles of drug candidates at various pharmacological barriers and Transporter induced drug- drug interactions. Solvo Biotechnology has been the pioneer and the leader in the commercialization of Membrane Transporter technologies, including therapeutics, diagnostics and drug discovery assays. The company offers drug discovery products and services to pharmaceutical, biotechnology and consumer goods industries, relevant to many therapeutic areas and product categories. All major pharma and biotech companies use SOLVO’s assays, either in-house, or as contracted research.